| Management number | 233411017 | Release Date | 2026/06/27 | List Price | US$59.64 | Model Number | 233411017 | ||
|---|---|---|---|---|---|---|---|---|---|
| Category | |||||||||
Current Status of Prostate Cancer: Diagnosis, Biomarkers and Therapies, Volume 161 in the Advances in Cancer Research series, covers timely topics such as The Prostate Cancer Tissue N-glycome as a Source of Biomarkers, a Progression from Normal to Metastatic Disease, Multiplexed Targeted Proteomics for Prostate Cancer Biomarker Verification, MRI for the Detection of Clinically Significant Prostate Cancer: Update and Future Directions, Genetic and epigenetic factors for prostate cancer progression, Epigenetic regulation of androgen dependent and independent prostate cancer, Molecular Landscape of Prostate Cancer Bone Metastasis, Future of radioligand Therapy in PC, and more.Additional chapters of note include Advancements in Computer Vision and Pathology: Unraveling the Potential of Artificial Intelligence for Precision Diagnosis and Beyond and Extracellular Vesicles in Prostate Cancer.- Provides the latest information on cancer research- Offers outstanding and original reviews on a range of cancer research topics- Serves as an indispensable reference for researchers and students alike Read more
| ASIN | B0DBD76GYM |
|---|---|
| XRay | Not Enabled |
| ISBN13 | 978-0443296291 |
| Language | English |
| File size | 17.3 MB |
| Page Flip | Enabled |
| Publisher | Academic Press |
| Word Wise | Not Enabled |
| Print length | 789 pages |
| Accessibility | Learn more |
| Screen Reader | Supported |
| Publication date | July 20, 2024 |
| Enhanced typesetting | Enabled |
If you notice any omissions or errors in the product information on this page, please use the correction request form below.
Correction Request Form